Annual SGA
$7.30 B
-$82.84 M-1.12%
March 31, 2024
Summary
- As of February 7, 2025, TAK annual SGA is $7.30 billion, with the most recent change of -$82.84 million (-1.12%) on March 31, 2024.
- During the last 3 years, TAK annual SGA has fallen by -$957.50 million (-11.59%).
- TAK annual SGA is now -28.90% below its all-time high of $10.27 billion, reached on March 31, 2012.
Performance
TAK SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$1.77 B
-$32.18 M-1.78%
December 1, 2024
Summary
- As of February 7, 2025, TAK quarterly SGA is $1.77 billion, with the most recent change of -$32.18 million (-1.78%) on December 1, 2024.
- Over the past year, TAK quarterly SGA has dropped by -$32.18 million (-1.78%).
- TAK quarterly SGA is now -27.62% below its all-time high of $2.45 billion, reached on March 31, 2019.
Performance
TAK Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
$35.75 B
-$1.68 B-4.50%
December 1, 2024
Summary
- As of February 7, 2025, TAK TTM SGA is $35.75 billion, with the most recent change of -$1.68 billion (-4.50%) on December 1, 2024.
- Over the past year, TAK TTM SGA has increased by +$28.48 billion (+391.65%).
- TAK TTM SGA is now -69.03% below its all-time high of $115.44 billion.
Performance
TAK TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
TAK Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.1% | -1.8% | +391.6% |
| 3 y3 years | -11.6% | -8.0% | +384.7% |
| 5 y5 years | +12.8% | -19.8% | +332.7% |
TAK Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -11.6% | at low | -12.7% | +2.4% | -33.7% | at low |
| 5 y | 5-year | -17.7% | +12.8% | -23.7% | +2.4% | -33.7% | at low |
| alltime | all time | -28.9% | +153.6% | -27.6% | +42.8% | -69.0% | +56.8% |
Takeda Pharmaceutical Company Limited Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | $1.77 B(-1.8%) | $7.23 B(-0.5%) |
| Sep 2024 | - | $1.81 B(+4.3%) | $7.27 B(+0.8%) |
| Jun 2024 | - | $1.73 B(-9.9%) | $7.22 B(-1.0%) |
| Mar 2024 | $7.30 B(-1.1%) | $1.92 B(+6.1%) | $7.29 B(-0.1%) |
| Dec 2023 | - | $1.81 B(+3.5%) | $7.30 B(-0.7%) |
| Sep 2023 | - | $1.75 B(-3.2%) | $7.35 B(-0.7%) |
| Jun 2023 | - | $1.81 B(-6.3%) | $7.40 B(+0.3%) |
| Mar 2023 | $7.39 B(-6.5%) | $1.93 B(+3.7%) | $7.38 B(+0.1%) |
| Dec 2022 | - | $1.86 B(+3.3%) | $7.37 B(-2.3%) |
| Sep 2022 | - | $1.80 B(+0.8%) | $7.54 B(-1.6%) |
| Jun 2022 | - | $1.79 B(-7.1%) | $7.67 B(-2.8%) |
| Mar 2022 | $7.90 B(-4.4%) | $1.92 B(-5.4%) | $7.89 B(-3.5%) |
| Dec 2021 | - | $2.03 B(+5.5%) | $8.18 B(-1.2%) |
| Sep 2021 | - | $1.93 B(-4.1%) | $8.28 B(-1.3%) |
| Jun 2021 | - | $2.01 B(-9.2%) | $8.39 B(+1.5%) |
| Mar 2021 | $8.26 B(-6.9%) | $2.21 B(+3.8%) | $8.26 B(-1.3%) |
| Dec 2020 | - | $2.13 B(+4.6%) | $8.37 B(-1.9%) |
| Sep 2020 | - | $2.04 B(+8.4%) | $8.53 B(-0.5%) |
| Jun 2020 | - | $1.88 B(-19.1%) | $8.58 B(-3.3%) |
| Mar 2020 | $8.88 B(+37.1%) | $2.32 B(+1.4%) | $8.87 B(-1.4%) |
| Dec 2019 | - | $2.29 B(+10.1%) | $9.00 B(+11.5%) |
| Sep 2019 | - | $2.08 B(-4.4%) | $8.07 B(+10.2%) |
| Jun 2019 | - | $2.18 B(-11.2%) | $7.33 B(+13.1%) |
| Mar 2019 | $6.47 B(+14.2%) | $2.45 B(+79.6%) | $6.48 B(+15.4%) |
| Dec 2018 | - | $1.37 B(+2.3%) | $5.61 B(-0.8%) |
| Sep 2018 | - | $1.33 B(+0.4%) | $5.66 B(-0.5%) |
| Jun 2018 | - | $1.33 B(-16.1%) | $5.69 B(+0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | $5.67 B(-1.0%) | $1.58 B(+12.5%) | $5.67 B(+0.1%) |
| Dec 2017 | - | $1.41 B(+3.2%) | $5.67 B(+0.9%) |
| Sep 2017 | - | $1.36 B(+4.0%) | $5.62 B(-1.1%) |
| Jun 2017 | - | $1.31 B(-16.9%) | $5.68 B(-0.5%) |
| Mar 2017 | $5.72 B(+5.6%) | $1.58 B(+16.2%) | $5.71 B(+1.0%) |
| Dec 2016 | - | $1.36 B(-4.6%) | $5.65 B(+0.5%) |
| Sep 2016 | - | $1.43 B(+6.3%) | $5.62 B(+3.4%) |
| Jun 2016 | - | $1.34 B(-11.8%) | $5.44 B(+0.2%) |
| Mar 2016 | $5.42 B(-3.2%) | $1.52 B(+14.0%) | $5.43 B(+1.0%) |
| Dec 2015 | - | $1.33 B(+7.4%) | $5.37 B(-0.4%) |
| Sep 2015 | - | $1.24 B(-6.8%) | $5.39 B(-3.0%) |
| Jun 2015 | - | $1.33 B(-9.0%) | $5.56 B(-0.1%) |
| Mar 2015 | $5.60 B(+0.9%) | $1.47 B(+8.2%) | $5.57 B(-1.1%) |
| Dec 2014 | - | $1.35 B(-4.0%) | $5.63 B(-0.4%) |
| Sep 2014 | - | $1.41 B(+5.5%) | $5.65 B(+1.5%) |
| Jun 2014 | - | $1.34 B(-12.6%) | $5.57 B(+0.4%) |
| Mar 2014 | $5.55 B(-10.5%) | $1.53 B(+11.1%) | $5.54 B(+38.1%) |
| Dec 2013 | - | $1.38 B(+4.0%) | $4.01 B(+52.2%) |
| Sep 2013 | - | $1.32 B(+0.9%) | $2.64 B(+100.9%) |
| Jun 2013 | - | $1.31 B | $1.31 B |
| Mar 2013 | $6.21 B(-39.6%) | - | - |
| Mar 2012 | $10.27 B(+20.4%) | - | - |
| Mar 2011 | $8.53 B(+4.1%) | - | - |
| Mar 2010 | $8.20 B(-13.5%) | - | - |
| Mar 2009 | $9.48 B(+60.5%) | - | - |
| Mar 2008 | $5.91 B(+105.1%) | - | - |
| Mar 2000 | $2.88 B | - | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual SGA?
- What is the all time high annual SGA for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual SGA year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly SGA?
- What is the all time high quarterly SGA for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly SGA year-on-year change?
- What is Takeda Pharmaceutical Company Limited TTM SGA?
- What is the all time high TTM SGA for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited TTM SGA year-on-year change?
What is Takeda Pharmaceutical Company Limited annual SGA?
The current annual SGA of TAK is $7.30 B
What is the all time high annual SGA for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual SGA is $10.27 B
What is Takeda Pharmaceutical Company Limited annual SGA year-on-year change?
Over the past year, TAK annual SGA has changed by -$82.84 M (-1.12%)
What is Takeda Pharmaceutical Company Limited quarterly SGA?
The current quarterly SGA of TAK is $1.77 B
What is the all time high quarterly SGA for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly SGA is $2.45 B
What is Takeda Pharmaceutical Company Limited quarterly SGA year-on-year change?
Over the past year, TAK quarterly SGA has changed by -$32.18 M (-1.78%)
What is Takeda Pharmaceutical Company Limited TTM SGA?
The current TTM SGA of TAK is $35.75 B
What is the all time high TTM SGA for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high TTM SGA is $115.44 B
What is Takeda Pharmaceutical Company Limited TTM SGA year-on-year change?
Over the past year, TAK TTM SGA has changed by +$28.48 B (+391.65%)